PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
47.09
ESG score below 80% of ANVS's 62.21. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
27.98
Environmental score below 80% of ANVS's 47.17. Jim Chanos would check for potential stranded asset risks and carbon liabilities.
55.14
Social score 80-90% of ANVS's 64.21. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
58.16
Governance score below 80% of ANVS's 75.24. Jim Chanos would check for potential agency conflicts and oversight failures.